“Development of Nanocrystal Formulations With Improved Dissolution And Bioavailability for BCS Classs-II Drug- Quitapine”. Journal of Pharmaceutical Negative Results, Aug. 2022, pp. 5113-20, https://doi.org/10.47750/pnr.2022.13.S08.670.